Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

9176

1

HeartCore Enterprises, Inc. HeartCore Enterprises Reports 280.7% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9177

1

ABVC BIOPHARMA, INC. ABVC BioPharma Reports 2,351% Revenue Growth, Net Loss Reduction in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9178

1

Luvu Brands, Inc. Luvu Brands Reports Decline in Net Sales and Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9179

1

Candel Therapeutics, Inc. Candel Therapeutics Reports Significant Financial Challenges, Faces Doubt Over Ability to Continue as a Going Concern

Via official filing (AI summary) | 6 months ago | 0 comments

9180

1

Silexion Therapeutics Corp Silexion Therapeutics Reports Significant Net Loss and Operating Expenses Increase in Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9181

1

Inhibikase Therapeutics, Inc. Inhibikase Therapeutics Reports Significant Financial Challenges, Raises $110M in Private Placement

Via official filing (AI summary) | 6 months ago | 0 comments

9182

1

TANCHENG GROUP CO., LTD. Tancheng Group Reports Significant Declines in Financial Performance for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9183

1

Bimergen Energy Corp Bitech Technologies Reports Significant Financial Changes, Net Loss, and Shift to Green Energy Focus

Via official filing (AI summary) | 6 months ago | 0 comments

9184

1

Mawson Infrastructure Group Inc. Mawson Infrastructure Group Reports Revenue Growth, Improved Profitability, and Strategic Developments in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9185

1

Zoned Properties, Inc. Zoned Properties Reports 43% Revenue Growth, Net Income Recovery in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9186

1

Rani Therapeutics Holdings, Inc. Rani Therapeutics Reports 33.9% Decrease in Operating Expenses, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9187

1

Hyzon Motors Inc. Hyzon Motors Reports Decline in Financial Metrics, Revenue Growth Amid Restructuring Efforts

Via official filing (AI summary) | 6 months ago | 0 comments

9188

1

Earth Science Tech, Inc. Earth Science Tech Reports Significant Revenue and Net Income Growth in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9189

1

Sow Good Inc. Sow Good Inc. Reports Mixed Quarterly Results, But Sees Significant Growth in Revenues and Assets

Via official filing (AI summary) | 6 months ago | 0 comments

9190

1

CURIS INC Curis, Inc. Reports Revenue Growth, Net Loss, and Cash Decline in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9191

1

iQSTEL Inc iQSTEL Inc. Reports Significant Revenue Growth, Widening Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9192

1

Sensei Biotherapeutics, Inc. Sensei Biotherapeutics Reports Q3 Financial Results, Announces Restructuring Plan

Via official filing (AI summary) | 6 months ago | 0 comments

9193

1

Sagimet Biosciences Inc. Sagimet Biosciences Reports Increased Assets, Wider Losses in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9194

1

Talen Energy Corp Talen Energy Reports Significant Financial Improvements in Q3 and Nine-Month Periods

Via official filing (AI summary) | 6 months ago | 0 comments

9195

1

Nuvera Communications, Inc. Nuvera Communications Reports Mixed Q3 Results, Revenue Growth Offset by Decline in Net Income

Via official filing (AI summary) | 6 months ago | 0 comments

9196

1

ZyVersa Therapeutics, Inc. ZyVersa Therapeutics Reports Significant Financial Challenges, Decreased Cash Position, and Ongoing Operating Losses in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9197

1

Odysight.ai Inc. Odysight.ai Reports 145% Revenue Growth, Net Loss in 9-Month Period Ending September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9198

1

Guerrilla RF, Inc. Guerrilla RF Reports 52% Revenue Growth, Improved Cash Position, and Restructured Debt for Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9199

1

GALECTIN THERAPEUTICS INC Galectin Therapeutics Reports Third Quarter Loss, Cash and Cash Equivalents Increase

Via official filing (AI summary) | 6 months ago | 0 comments

9200

1

Leet Technology Inc. Leet Technology Reports Significant Revenue Growth and Net Profit in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments